descemet stripping automated endothelial keratoplasty in patients with toxic anterior segment...
TRANSCRIPT
![Page 1: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/1.jpg)
Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced
endothelial failure
First and Presenting author: Jeewan S. TitiyalCo-authors: Tarun Arora, Manpreet Kaur, Tushar Agarwal
Affiliation: RP Centre, AIIMS, New Delhi, India
None of the authors of this poster have any financial interests
![Page 2: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/2.jpg)
Purpose
To evaluate the factors responsible for success and
failure of Descemet Stripping Automated Endothelial
Keratoplasty (DSAEK) in patients with Toxic anterior
segment syndrome (TASS) induced endothelial failure
![Page 3: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/3.jpg)
Methodology
• Type of study: Retrospective case series
• Number of cases = 5
• Inclusion criteria: Patients with endothelial failure as a
result of TASS, post phacoemulsification surgery and
IOP ≤ 24 mm Hg with or without medications
![Page 4: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/4.jpg)
Parameters Evaluated
• Demographic profile
• Preoperative Endothelial count, Central corneal thickness
(CCT), Intraocular pressure (IOP)
• Time interval of DSAEK surgery from onset of TASS
• Intraoperative challenges and complications during
DSAEK surgery
![Page 5: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/5.jpg)
Outcome measures (at
final visit)
• Best-corrected visual acuity
• Intraocular pressure
• Graft clarity
• Donor and host corneal thickness
• Specular count
![Page 6: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/6.jpg)
Results
• Mean (±SD) age was 58.6 (±4.04) years
• Mean (±SD) preoperative CCT was 615.4 (±46.8)
microns
• Mean(±SD) preoperative specular count was
433.4(±40.6) cells/mm2
![Page 7: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/7.jpg)
Results (contd.)• Mean (±SD) follow up was 15.3 (±5.2) months (range 6 – 24 months)
• At final follow up
o Three cases (60%) maintained clear graft with BCVA ≥ 20/40,
mean (±SD) host thickness: 414.3 ± 25.1 microns, mean (±SD)
donor thickness: 140.2 ± 21.1 microns
o Two cases had graft failure with BCVA < 20/200, mean (±SD) host
thickness: 544.2 ± 32.3 microns, mean (±SD) donor thickness:
221.5 ± 42.3 microns and raised IOP (>24m Hg)
![Page 8: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/8.jpg)
Results (contd.)
• Average time interval between episode of TASS and
successful DSAEK surgeries: 126.7 days
• Average time interval between episode of TASS and
failed DSAEK surgeries: 31 days
![Page 9: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/9.jpg)
Patient detailsSerial No.
Age Sex Time Interval between TASS and DSAEK
Graft Clarity
BCDVA
IOP Complications
1 54 M 27 0 PL+ 28 Floppy iris, secondary glaucoma
2 62 M 35 0 PL+ 30 Increased anterior chamber inflammation, secondary glaucoma
3 55 F 120 4 20/30 20 -
4 59 F 128 4 20/30 16 -
5 63 M 132 3 20/40 18 -
![Page 10: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/10.jpg)
Results (contd.)Possible factors for graft failure
• Floppy iris leading to extensive peripheral anterior synechiae,
• Postoperative exacerbated inflammation, pigment release and
• Increased intraocular pressure
![Page 11: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/11.jpg)
Conclusion
Early DSAEK surgery in patients with endothelial failure
as a result of TASS are associated with increased
postoperative inflammation and raised IOP which may
eventually lead to poor outcome of DSAEK surgery
![Page 12: Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting](https://reader035.vdocument.in/reader035/viewer/2022080223/56649f1b5503460f94c312f6/html5/thumbnails/12.jpg)
ConclusionDelayed DSAEK surgery after proper control of
inflammation and intraocular pressure leads to excellent
outcomes in cases with endothelial failure due to Toxic
anterior segment syndrome